Urogenital Neoplasms
Showing 26 - 50 of 1,033
Impact of COVID-19 on GU Disease
Recruiting
- COVID-19 Infection
- +2 more
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Sep 13, 2022
Integrated Molecular Profiling in Advanced Cancers Trial
Active, not recruiting
- Breast Cancer
- +9 more
-
Toronto, Ontario, CanadaPrincess Margaret Hospital
Sep 26, 2022
Prostate Tumor, Genital Tumors, Male, Urogenital Tumors Trial in Miami, Chicago (Cultural CBSM, Standard CBSM)
Recruiting
- Prostate Neoplasm
- +5 more
- Cultural CBSM
- Standard CBSM
-
Miami, Florida
- +1 more
Dec 2, 2021
Prostate Cancer, Prostatic Tumor, Prostatic Disease Trial in Vancouver ([68Ga]Ga-HTK03149 PET/CT)
Active, not recruiting
- Prostate Cancer
- +5 more
- [68Ga]Ga-HTK03149 PET/CT
-
Vancouver, British Columbia, CanadaBC Cancer
Dec 1, 2021
Genito-Urinary Tumor Trial in Duarte (Biospecimen Collection(Punch Biopsy))
Active, not recruiting
- Genito-Urinary Neoplasm
- Biospecimen Collection(Punch Biopsy)
-
Duarte, CaliforniaCity of Hope Medical Center
Nov 22, 2022
Rapid Autopsy and Procurement of Cancer Tissue
Recruiting
- Thymus Tumors
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 20, 2022
Prostatic Tumors, Castration-Resistant, Tumors by Histologic Type, Tumors, Prostate Trial in United States (P-PSMA-101 CAR-T
Active, not recruiting
- Prostatic Neoplasms, Castration-Resistant
- +16 more
- P-PSMA-101 CAR-T cells
- Rimiducid
-
Duarte, California
- +9 more
Nov 15, 2022
Colitis, Diarrhea, Malignant Genitourinary System Tumor Trial in Houston (Fecal Microbiota Transplantation, Loperamide)
Recruiting
- Colitis
- +8 more
- Fecal Microbiota Transplantation
- Loperamide
-
Houston, TexasM D Anderson Cancer Center
Oct 17, 2022
Cancer, Cancer CNS, Cancer Thoracic Trial in Duarte, Dallas (Registry - Observational)
Recruiting
- Cancer
- +7 more
- Registry - Observational
-
Duarte, California
- +1 more
Aug 5, 2022
Metastatic Cancer, Locally Advanced Cancer, Thoracic Cancer Trial in New York (Weekly 45 minute Sessions)
Active, not recruiting
- Metastatic Cancer
- +5 more
- Weekly 45 minute Sessions
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Aug 19, 2022
Endocrine/Neuroendocrine, NSCLC, Breast Cancer Trial run by the National Cancer Institute (NCI) (Fludarabine, Cyclophosphamide,
Recruiting
- Endocrine/Neuroendocrine
- +4 more
- Fludarabine
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 24, 2022
Urothelial Carcinoma, Anlotinib, Urogenital Tumors Trial in Tianjin (Anlotinib, Cisplatin, Carboplatin)
Not yet recruiting
- Urothelial Carcinoma
- +6 more
- Anlotinib
- +3 more
-
Tianjin, ChinaTianjin Medical Unversity Second Hospital
Aug 30, 2021
Bladder Cancer, Urothelial Carcinoma, Urinary Bladder Tumor Trial in United States (NanoDoce (direct injection), NanoDoce
Completed
- Bladder Cancer
- +8 more
- NanoDoce (direct injection)
- +3 more
-
Phoenix, Arizona
- +4 more
Nov 29, 2021
Ontario-wide Cancer TArgeted Nucleic Acid Evaluation
Recruiting
- Breast Cancer
- +10 more
-
Hamilton, Ontario, Canada
- +6 more
Apr 21, 2022
Malignant Genito-urinary Tumors in Children: South Egypt Cancer
Recruiting
- Genitourinary Neoplasms
- Neoplasms, Genitourinary
-
Assiut, EgyptAssiut University
Jul 24, 2021
Circulating Tumor DNA for Early Treatment Response Assessment of
Recruiting
- Healthy Volunteer
- +12 more
-
Saint Louis, MissouriWashington University School of Medicine
Apr 4, 2022
Bladder Cancer, Renal Cancer Trial in Minsk (cytokine-induced killer cells, Standard treatment according to the Clinical
Not yet recruiting
- Bladder Cancer
- Renal Cancer
- cytokine-induced killer cells
- Standard treatment according to the Clinical protocols
-
Minsk, BelarusInstitute of Biophysics and Cell Engineering of National Academy
Jan 12, 2022
Urinary Bladder Tumors, Urologic Tumors, Urogenital Tumors Trial in Shanghai (tislelizumab and BCG)
Recruiting
- Urinary Bladder Neoplasms
- +5 more
- tislelizumab and BCG
-
Shanghai, Shanghai, ChinaRen Ji Hospital, School of Medicine, Shanghai Jiao Tong Universi
Jun 10, 2021
Prostate Cancer, Erectile Dysfunction Trial in San Diego (Sham Magnetic stimulation)
Enrolling by invitation
- Prostate Cancer
- Erectile Dysfunction
- Sham Magnetic stimulation
-
San Diego, CaliforniaVA San Diego Healthcare System, San Diego, CA
Jan 12, 2022
Genitourinary Cancer, Adrenocortical Carcinoma, Non-urothelial Bladder Trial in United States (Ipilimumab, Nivolumab)
Recruiting
- Genitourinary Cancer
- +7 more
-
La Jolla, California
- +5 more
Jul 5, 2022
(Proteomic and Genomic Analysis of Biospecimens)
Enrolling by invitation
- Oncology
- +8 more
- Observational Study Only. NO Intervention.
-
New Orleans, LouisianaAUD
Jun 2, 2023
Urinary Bladder Tumor, Transitional Cell Carcinoma, Urogenital Tumors Trial in Hall In Tirol, Salzburg (Bipolar transurethral
Recruiting
- Urinary Bladder Neoplasm
- +4 more
- Bipolar transurethral resection of bladder tumor (TURBT)
- Bipolar transurethral plasma kinetic vaporization of bladder tumor (PKVBT)
-
Hall In Tirol, Austria
- +1 more
Mar 19, 2021
Metastatic Renal Cell Carcinoma, Kidney Tumor, Urologic Tumors Trial in Herlev (Medication (A specification is listed under each
Recruiting
- Metastatic Renal Cell Carcinoma
- +3 more
- Medication (A specification is listed under each arm)
- Patient reported outcomes measurement
-
Herlev, DenmarkDepartment of Oncology, Herlev and Gentofte Hospital
Nov 19, 2020
Abdominal Hernia, Abdominal Wall Defect, Abdominal Tumor Trial in La Louvière (VPC syringe)
Recruiting
- Abdominal Hernia
- +6 more
- VPC syringe
-
La Louvière, Hainaut, BelgiumChu Tivoli
Apr 1, 2022